Human medicines European public assessment report (EPAR): Nuvaxovid, COVID-19 Vaccine (recombinant, 08 november Human medicines European public assessment report (EPAR): Nuvaxovid, COVID-19 Vaccine (recombinant, Human medicines European public assessment report (EPAR): Nuvaxovid, COVID-19 Vaccine (recombinant, adjuvanted), COVID-19 virus infection, Date of authorisation: 20/12/2021, Revision: 11, Status: Authorised Lees verder » Wil je het laatste nieuws in jouw mailbox? Meld je dan aan voor de nieuwsbrief.